| Field | Row 1 |
|---|---|
| adsh | 0001558370-25-007462 |
| cik | 1711933 |
| name | AKOYA BIOSCIENCES, INC. |
| sic | 3826 |
| countryba | US |
| stprba | MA |
| cityba | MARLBOROUGH |
| zipba | 01762 |
| bas1 | 100 CAMPUS DRIVE |
| bas2 | 6TH FLOOR |
| baph | 855.896.8401 |
| countryma | US |
| stprma | MA |
| cityma | MARLBOROUGH |
| zipma | 01762 |
| mas1 | 100 CAMPUS DRIVE |
| mas2 | 6TH FLOOR |
| countryinc | US |
| stprinc | DE |
| ein | 475586242 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250513 |
| accepted | 2025-05-12 19:44:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | akya-20250331x10q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001558370-25-007462 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 7000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Additional Paid In Capital | 293022000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2566000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Asset Impairment Charges | 2971000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Asset Impairment Charges | 2069000.0000 | USD | 1 | us-gaap/2023 | Property Plant And Equipment By Type= Property Plant And Equipment Other Types; | ||
| 0001558370-25-007462 | 20240331 | Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | 179000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 12465000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20221031 | Common Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2023 | Subsidiary Sale Of Stock= Piper Sandler And Co. Equity Distribution Agreement; | ||
| 0001558370-25-007462 | 20240331 | Cost Of Revenue | 3248000.0000 | USD | 1 | us-gaap/2023 | Product Or Service= Service; | ||
| 0001558370-25-007462 | 20250331 | Cost Of Revenue | 2277000.0000 | USD | 1 | us-gaap/2023 | Product Or Service= Service; | ||
| 0001558370-25-007462 | 20250331 | Deferred Income Tax Expense Benefit | 11000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Earnings Per Share Basic | -0.4800 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Earnings Per Share Basic | -0.3200 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Finance Lease Principal Payments | 180000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Finance Lease Right Of Use Asset | 1525000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Goodwill | 18262000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Gross Profit | 8379000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Increase Decrease In Accrued Liabilities | -27000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 471000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Intangible Assets Net Excluding Goodwill | 14559000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Intangible Assets Net Excluding Goodwill | 13845000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Interest Income Expense Nonoperating Net | -2612000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Liabilities | 117410000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Liabilities | 118538000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Net Cash Provided By Used In Investing Activities | -48817000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Net Income Loss | -23484000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Net Income Loss | -15652000.0000 | USD | 1 | us-gaap/2023 | Business Segments= Single Reportable Segment; | ||
| 0001558370-25-007462 | 20250331 | Other Liabilities Noncurrent | 40000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Restricted Stock Expense | 77000.0000 | USD | 1 | us-gaap/2023 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007462 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 10124000.0000 | USD | 1 | us-gaap/2023 | Geographical= North America; | ||
| 0001558370-25-007462 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 6210000.0000 | USD | 1 | us-gaap/2023 | Product Or Service= Service; | ||
| 0001558370-25-007462 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 270000.0000 | USD | 1 | us-gaap/2023 | Product Or Service= Standalone Software Products; | ||
| 0001558370-25-007462 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 10138000.0000 | USD | 1 | us-gaap/2023 | Geographical= North America; | ||
| 0001558370-25-007462 | 20250331 | Share Based Compensation | 2246000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Stockholders Equity | 286292000.0000 | USD | 0 | us-gaap/2023 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007462 | 20240331 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2023 | Equity Components= Common Stock; | ||
| 0001558370-25-007462 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 36000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 36000.0000 | USD | 1 | us-gaap/2023 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007462 | 20241231 | Accounts Receivable Net Current | 13779000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Additional Paid In Capital | 295198000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Assets Current | 66212000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | 179000.0000 | USD | 1 | us-gaap/2023 | Business Segments= Single Reportable Segment; | ||
| 0001558370-25-007462 | 20241231 | Business Combination Contingent Consideration Liability Noncurrent | 3871000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Common Stock Shares Issued | 49572122.0000 | shares | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Cost Of Revenue | 1673000.0000 | USD | 1 | us-gaap/2023 | Counterparty Name= Argonaut Manufacturing Services; | ||
| 0001558370-25-007462 | 20241231 | Deferred Income Tax Liabilities Net | 129000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Demo Inventory Net | 1336000.0000 | USD | 0 | 0001558370-25-007462 | |||
| 0001558370-25-007462 | 20250331 | Demo Inventory Net | 1119000.0000 | USD | 0 | 0001558370-25-007462 | |||
| 0001558370-25-007462 | 20240331 | Earnings Per Share Diluted | -0.4800 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Finance Lease Liability Current | 506000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Finance Lease Liability Noncurrent | 616000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Finance Lease Right Of Use Asset | 1307000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Goodwill | 18262000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Increase Decrease In Accounts Payable | 1532000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Interest And Other Income | 937000.0000 | USD | 1 | us-gaap/2023 | Business Segments= Single Reportable Segment; | ||
| 0001558370-25-007462 | 20250331 | Interest And Other Income | 313000.0000 | USD | 1 | us-gaap/2023 | Business Segments= Single Reportable Segment; | ||
| 0001558370-25-007462 | 20240331 | Interest Income Expense Nonoperating Net | -2612000.0000 | USD | 1 | us-gaap/2023 | Business Segments= Single Reportable Segment; | ||
| 0001558370-25-007462 | 20240331 | Net Cash Provided By Used In Financing Activities | -444000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Net Cash Provided By Used In Financing Activities | -250000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Net Cash Provided By Used In Operating Activities | -20824000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Net Income Loss | -23484000.0000 | USD | 1 | us-gaap/2023 | Business Segments= Single Reportable Segment; | ||
| 0001558370-25-007462 | 20250331 | Net Income Loss | -15652000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Operating Income Loss | -21585000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Operating Lease Right Of Use Asset | 3859000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -16000.0000 | USD | 1 | us-gaap/2023 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-007462 | 20250331 | Other Nonoperating Income Expense | -13000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Payments Related To Tax Withholding For Share Based Compensation | 149000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Payments To Acquire Marketable Securities | 48007000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Proceeds From Stock Options Exercised | 36000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Profit Loss | -15652000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Property Plant And Equipment Net | 2115000.0000 | USD | 0 | us-gaap/2023 | Property Plant And Equipment By Type= Facility Not Being Used; | ||
| 0001558370-25-007462 | 20250331 | Research And Development Expense | 5557000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 7001000.0000 | USD | 1 | us-gaap/2023 | Product Or Service= Consumables; | ||
| 0001558370-25-007462 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 16639000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 5030000.0000 | USD | 1 | us-gaap/2023 | Product Or Service= Instruments; | ||
| 0001558370-25-007462 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 58000.0000 | USD | 1 | us-gaap/2023 | Product Or Service= Standalone Software Products; | ||
| 0001558370-25-007462 | 20240331 | Stockholders Equity | -16000.0000 | USD | 0 | us-gaap/2023 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-007462 | 20241231 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2023 | Equity Components= Common Stock; | ||
| 0001558370-25-007462 | 20241231 | Stockholders Equity | -285436000.0000 | USD | 0 | us-gaap/2023 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007462 | 20250331 | Stockholders Equity | 295198000.0000 | USD | 0 | us-gaap/2023 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007462 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 65482.0000 | shares | 1 | us-gaap/2023 | Equity Components= Common Stock; | ||
| 0001558370-25-007462 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 49188170.0000 | shares | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Accrued Liabilities Current | 10848000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | -1000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2566000.0000 | USD | 1 | us-gaap/2023 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007462 | 20240331 | Amortization Of Debt Discount Premium | 215000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Asset Impairment Charges | 2971000.0000 | USD | 1 | us-gaap/2023 | Business Segments= Single Reportable Segment; | ||
| 0001558370-25-007462 | 20241231 | Assets | 125005000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 83824000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250430 | Common Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2023 | Business Acquisition= Akoya Biosciences Inc; Legal Entity= Quanterix Corporation; | ||
| 0001558370-25-007462 | 20241231 | Common Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2023 | Employee Stock Ownership Plan E S O P Disclosures By Plan= Employee Stock Purchase Plan; | ||
| 0001558370-25-007462 | 20241231 | Common Stock Shares Outstanding | 49572122.0000 | shares | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Common Stock Value | 2000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Comprehensive Income Net Of Tax | -15660000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Cost Of Revenue | 6723000.0000 | USD | 1 | us-gaap/2023 | Product Or Service= Product; | ||
| 0001558370-25-007462 | 20250331 | Cost Of Revenue | 6768000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Cost Of Revenue | 6615000.0000 | USD | 1 | us-gaap/2023 | Business Segments= Single Reportable Segment; | ||
| 0001558370-25-007462 | 20250331 | Deferred Income Tax Liabilities Net | 140000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Finance Lease Liability Current | 609000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Finance Lease Liability Noncurrent | 693000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Finance Lease Principal Payments | 181000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Gross Profit | 9871000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -23421000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Increase Decrease In Accounts Receivable | -1982000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Increase Decrease In Contract With Customer Liability | -317000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Interest Income Expense Nonoperating Net | -2492000.0000 | USD | 1 | us-gaap/2023 | Business Segments= Single Reportable Segment; | ||
| 0001558370-25-007462 | 20240331 | Interest Paid Net | 2243000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Interest Paid Net | 2122000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Liabilities Current | 108082000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Long Term Debt Noncurrent | 76182000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Operating Lease Liability Current | 2674000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Operating Lease Liability Current | 2708000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Other Assets Current | 3592000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Other Assets Current | 4073000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2023 | ||||
| 0001558370-25-007462 | 20240331 | Provision For Other Credit Losses | 375000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Research And Development Expense | 127000000.0000 | USD | 1 | us-gaap/2023 | Counterparty Name= Argonaut Manufacturing Services; | ||
| 0001558370-25-007462 | 20250331 | Restricted Stock Expense | 77000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 3270000.0000 | USD | 1 | us-gaap/2023 | Geographical= Asia Pacific; | ||
| 0001558370-25-007462 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 6944000.0000 | USD | 1 | us-gaap/2023 | Product Or Service= Consumables; | ||
| 0001558370-25-007462 | 20240331 | Stockholders Equity | 32723000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Stockholders Equity | -5889000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Stockholders Equity | -1000.0000 | USD | 0 | us-gaap/2023 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-007462 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 49664515.0000 | shares | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Investment Income Amortization Of Discount | 545000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Operating Lease Liability Noncurrent | 3406000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Payments To Acquire Marketable Securities | 3752000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Payments To Acquire Property Plant And Equipment | 810000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Payments To Acquire Property Plant And Equipment | 204000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2246000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Capital Expenditures Incurred But Not Yet Paid | 307000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Cash And Cash Equivalents At Carrying Value | 20357000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 8580000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Change In Inventory Reserve Adjustment | 2298000.0000 | USD | 1 | 0001558370-25-007462 | |||
| 0001558370-25-007462 | 20250331 | Change In Inventory Reserve Adjustment | 517000.0000 | USD | 1 | 0001558370-25-007462 | |||
| 0001558370-25-007462 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250430 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2023 | Business Acquisition= Akoya Biosciences Inc; Counterparty Name= Quanterix Shareholders; | ||
| 0001558370-25-007462 | 20241231 | Contract With Customer Liability Noncurrent | 3063000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Cost Of Revenue | 0.0000 | USD | 1 | us-gaap/2023 | Counterparty Name= Argonaut Manufacturing Services; | ||
| 0001558370-25-007462 | 20240331 | Deferred Income Tax Expense Benefit | 37000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Earnings Per Share Diluted | -0.3200 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -15604000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Increase Decrease In Inventories | 7310000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Restricted Stock Expense | 149000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Restricted Stock Expense | 149000.0000 | USD | 1 | us-gaap/2023 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007462 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 4956000.0000 | USD | 1 | us-gaap/2023 | Geographical= E M E A; | ||
| 0001558370-25-007462 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 12140000.0000 | USD | 1 | us-gaap/2023 | Product Or Service= Product; | ||
| 0001558370-25-007462 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 2585000.0000 | USD | 1 | us-gaap/2023 | Geographical= Asia Pacific; | ||
| 0001558370-25-007462 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 3916000.0000 | USD | 1 | us-gaap/2023 | Geographical= E M E A; | ||
| 0001558370-25-007462 | 20240331 | Shares Issued | 49340417.0000 | shares | 0 | us-gaap/2023 | Equity Components= Common Stock; | ||
| 0001558370-25-007462 | 20231231 | Stockholders Equity | 283839000.0000 | USD | 0 | us-gaap/2023 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007462 | 20231231 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2023 | Equity Components= Common Stock; | ||
| 0001558370-25-007462 | 20241231 | Stockholders Equity | 7595000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 49664515.0000 | shares | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Accounts Receivable Net Current | 11742000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Accrued Liabilities Current | 11572000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2246000.0000 | USD | 1 | us-gaap/2023 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007462 | 20250331 | Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | 146000.0000 | USD | 1 | us-gaap/2023 | Business Segments= Single Reportable Segment; | ||
| 0001558370-25-007462 | 20241231 | Cash And Cash Equivalents At Carrying Value | 11779000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Contract With Customer Liability Noncurrent | 2782000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Increase Decrease In Accounts Receivable | -3146000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Increase Decrease In Accrued Liabilities | -2133000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Increase Decrease In Contract With Customer Liability | -341000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Increase Decrease In Operating Lease Liabilities | -552000.0000 | USD | 1 | 0001558370-25-007462 | |||
| 0001558370-25-007462 | 20250331 | Interest And Other Income | 313000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Interest Income Expense Nonoperating Net | -2492000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Inventory Net | 22853000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Investment Income Amortization Of Discount | 182000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Long Term Debt Current | 76487000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Marketable Securities Current | 7187000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Net Cash Provided By Used In Investing Activities | 16044000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Operating Expenses | 29964000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Operating Income Loss | -13412000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Operating Lease Right Of Use Asset | 4255000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Other Assets Noncurrent | 437000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Other Liabilities Noncurrent | 40000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Other Nonoperating Income Expense | -161000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Research And Development Expense | 295000.0000 | USD | 1 | us-gaap/2023 | Related Party Transactions By Related Party= Officer; | ||
| 0001558370-25-007462 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 1752000.0000 | USD | 1 | us-gaap/2023 | Product Or Service= Service And Other; | ||
| 0001558370-25-007462 | 20250331 | Shares Issued | 49836931.0000 | shares | 0 | us-gaap/2023 | Equity Components= Common Stock; | ||
| 0001558370-25-007462 | 20231231 | Stockholders Equity | 53770000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Stockholders Equity | 293022000.0000 | USD | 0 | us-gaap/2023 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007462 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 7000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 7000.0000 | USD | 1 | us-gaap/2023 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007462 | 20240331 | Comprehensive Income Net Of Tax | -23500000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Cost Of Revenue | 9971000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Accounts Payable Current | 206000.0000 | USD | 0 | us-gaap/2023 | Related Party Transactions By Related Party= Officer; | ||
| 0001558370-25-007462 | 20250331 | Accounts Payable Current | 10291000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Amortization Of Debt Discount Premium | 305000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Asset Impairment Charges | 902000.0000 | USD | 1 | us-gaap/2023 | Property Plant And Equipment By Type= Right Of Use; | ||
| 0001558370-25-007462 | 20250331 | Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | 146000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 13739000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 21045000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Common Stock Shares Outstanding | 49836931.0000 | shares | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Income Tax Expense Benefit | 48000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Liabilities And Stockholders Equity | 112649000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Liabilities Current | 29444000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Marketable Securities Current | 23261000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Net Cash Provided By Used In Operating Activities | -7214000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Net Income Loss | -23484000.0000 | USD | 1 | us-gaap/2023 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007462 | 20250331 | Operating Expenses | 23283000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Operating Lease Adjustment | 396000.0000 | USD | 1 | 0001558370-25-007462 | |||
| 0001558370-25-007462 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -16000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Other Nonoperating Income Expense | -161000.0000 | USD | 1 | us-gaap/2023 | Business Segments= Single Reportable Segment; | ||
| 0001558370-25-007462 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2023 | ||||
| 0001558370-25-007462 | 20250331 | Proceeds From Stock Options Exercised | 7000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Provision For Other Credit Losses | 55000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Refunds From Payments Of Deferred Offering Costs | -150000.0000 | USD | 1 | 0001558370-25-007462 | |||
| 0001558370-25-007462 | 20250331 | Retained Earnings Accumulated Deficit | -301088000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 18350000.0000 | USD | 1 | us-gaap/2023 | Business Segments= Single Reportable Segment; | ||
| 0001558370-25-007462 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 2855000.0000 | USD | 1 | us-gaap/2023 | Product Or Service= Instrument Warranty; | ||
| 0001558370-25-007462 | 20240331 | Selling General And Administrative Expense | 19863000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20231231 | Stockholders Equity | -230071000.0000 | USD | 0 | us-gaap/2023 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007462 | 20241231 | Stockholders Equity | 7000.0000 | USD | 0 | us-gaap/2023 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-007462 | 20250331 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2023 | Equity Components= Common Stock; | ||
| 0001558370-25-007462 | 20250331 | Increase Decrease In Inventories | -995000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Accounts Payable Current | 8759000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Assets | 112649000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Assets Current | 76732000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Business Combination Contingent Consideration Liability Noncurrent | 3472000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Capital Expenditures Incurred But Not Yet Paid | 84000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Common Stock Shares Issued | 49836931.0000 | shares | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Common Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2023 | Employee Stock Ownership Plan E S O P Disclosures By Plan= Employee Stock Purchase Plan; | ||
| 0001558370-25-007462 | 20241231 | Common Stock Value | 2000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Contract With Customer Liability Current | 6518000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Cost Of Revenue | 4491000.0000 | USD | 1 | us-gaap/2023 | Product Or Service= Product; | ||
| 0001558370-25-007462 | 20240331 | Income Tax Expense Benefit | 63000.0000 | USD | 1 | us-gaap/2023 | Business Segments= Single Reportable Segment; | ||
| 0001558370-25-007462 | 20250331 | Income Tax Expense Benefit | 48000.0000 | USD | 1 | us-gaap/2023 | Business Segments= Single Reportable Segment; | ||
| 0001558370-25-007462 | 20250331 | Increase Decrease In Operating Lease Liabilities | -548000.0000 | USD | 1 | 0001558370-25-007462 | |||
| 0001558370-25-007462 | 20241231 | Liabilities And Stockholders Equity | 125005000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Maturities Of Marketable Securities | 20000000.0000 | USD | 1 | 0001558370-25-007462 | |||
| 0001558370-25-007462 | 20250331 | Net Income Loss | -15652000.0000 | USD | 1 | us-gaap/2023 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007462 | 20241231 | Operating Lease Liability Noncurrent | 3988000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Other Assets Noncurrent | 447000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | -16000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | -8000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -8000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Other Nonoperating Income Expense | -13000.0000 | USD | 1 | us-gaap/2023 | Business Segments= Single Reportable Segment; | ||
| 0001558370-25-007462 | 20240331 | Other Restructuring Costs | 1397000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Payments Related To Tax Withholding For Share Based Compensation | 77000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Profit Loss | -23484000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Property Plant And Equipment Net | 7203000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Property Plant And Equipment Net | 6920000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Research And Development Expense | 5554000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Research And Development Expense | 135000.0000 | USD | 1 | us-gaap/2023 | Related Party Transactions By Related Party= Officer; | ||
| 0001558370-25-007462 | 20241231 | Restricted Cash Noncurrent | 686000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Restricted Cash Noncurrent | 688000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Restricted Stock Expense Number Of Shares | 157197.0000 | shares | 1 | 0001558370-25-007462 | Equity Components= Common Stock; | ||
| 0001558370-25-007462 | 20250331 | Restricted Stock Expense Number Of Shares | 257442.0000 | shares | 1 | 0001558370-25-007462 | Equity Components= Common Stock; | ||
| 0001558370-25-007462 | 20241231 | Retained Earnings Accumulated Deficit | -285436000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 18350000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 16639000.0000 | USD | 1 | us-gaap/2023 | Business Segments= Single Reportable Segment; | ||
| 0001558370-25-007462 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 12032000.0000 | USD | 1 | us-gaap/2023 | Product Or Service= Product; | ||
| 0001558370-25-007462 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 4607000.0000 | USD | 1 | us-gaap/2023 | Product Or Service= Service; | ||
| 0001558370-25-007462 | 20250331 | Selling General And Administrative Expense | 17580000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Share Based Compensation | 2566000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Shares Issued | 49572122.0000 | shares | 0 | us-gaap/2023 | Equity Components= Common Stock; | ||
| 0001558370-25-007462 | 20240331 | Stockholders Equity | -253555000.0000 | USD | 0 | us-gaap/2023 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007462 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 7367.0000 | shares | 1 | us-gaap/2023 | Equity Components= Common Stock; | ||
| 0001558370-25-007462 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 49188170.0000 | shares | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Accounts Payable Current | 581000.0000 | USD | 0 | us-gaap/2023 | Counterparty Name= Argonaut Manufacturing Services; | ||
| 0001558370-25-007462 | 20250331 | Accounts Payable Current | 173000.0000 | USD | 0 | us-gaap/2023 | Counterparty Name= Argonaut Manufacturing Services; | ||
| 0001558370-25-007462 | 20250331 | Accounts Payable Current | 178000.0000 | USD | 0 | us-gaap/2023 | Related Party Transactions By Related Party= Officer; | ||
| 0001558370-25-007462 | 20250331 | Asset Impairment Charges | 0.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -70085000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Contract With Customer Liability Current | 6554000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Cost Of Revenue | 9652000.0000 | USD | 1 | us-gaap/2023 | Business Segments= Single Reportable Segment; | ||
| 0001558370-25-007462 | 20240331 | Depreciation Depletion And Amortization | 2051000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Depreciation Depletion And Amortization | 1798000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Income Tax Expense Benefit | 63000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Increase Decrease In Accounts Payable | -1029000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -4000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Interest And Other Income | 937000.0000 | USD | 1 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20241231 | Inventory Net | 24321000.0000 | USD | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Operating Lease Adjustment | 728000.0000 | USD | 1 | 0001558370-25-007462 | |||
| 0001558370-25-007462 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -8000.0000 | USD | 1 | us-gaap/2023 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-007462 | 20250331 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2023 | |||
| 0001558370-25-007462 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 4869000.0000 | USD | 1 | us-gaap/2023 | Product Or Service= Instruments; | ||
| 0001558370-25-007462 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 2827000.0000 | USD | 1 | us-gaap/2023 | Product Or Service= Instrument Warranty; | ||
| 0001558370-25-007462 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 3383000.0000 | USD | 1 | us-gaap/2023 | Product Or Service= Service And Other; | ||
| 0001558370-25-007462 | 20231231 | Shares Issued | 49117738.0000 | shares | 0 | us-gaap/2023 | Equity Components= Common Stock; | ||
| 0001558370-25-007462 | 20250331 | Stockholders Equity | -301088000.0000 | USD | 0 | us-gaap/2023 | Equity Components= Retained Earnings; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Operating Lease Liability Noncurrent | us-gaap/2023 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2023 | 0 | 0 | monetary | I | C | Accumulated other comprehensive income | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Increase Decrease In Operating Lease Liabilities | 0001558370-25-007462 | 1 | 0 | monetary | D | D | Increase (Decrease) In Operating Lease Liabilities | The increase (decrease) during the reporting period in the aggregate amount of operating lease liabilities. |
| Business Combination Contingent Consideration Liability Noncurrent | us-gaap/2023 | 0 | 0 | monetary | I | C | Business Combination, Contingent Consideration, Liability, Noncurrent | Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2023 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2023 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Maturities Of Marketable Securities | 0001558370-25-007462 | 1 | 0 | monetary | D | D | Maturities of marketable securities | The cash inflow associated with the aggregate amount received by the entity through maturity of marketable securities (held-to-maturity or available-for-sale) during the period. |
| Contract With Customer Liability Noncurrent | us-gaap/2023 | 0 | 0 | monetary | I | C | Contract with Customer, Liability, Noncurrent | Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2023 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Interest Paid Net | us-gaap/2023 | 0 | 0 | monetary | D | C | Cash paid for interest | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Operating Income Loss | us-gaap/2023 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Other Assets Noncurrent | us-gaap/2023 | 0 | 0 | monetary | I | D | Other assets | Amount of noncurrent assets classified as other. |
| Preferred Stock Shares Authorized | us-gaap/2023 | 0 | 0 | shares | I | Preferred stock, shares authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Deferred Income Tax Liabilities Net | us-gaap/2023 | 0 | 0 | monetary | I | C | Deferred Income Tax Liabilities, Net | Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting. |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2023 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | Amount after tax of other comprehensive income (loss) attributable to parent entity. |
| Provision For Other Credit Losses | us-gaap/2023 | 0 | 0 | monetary | D | D | Provision for Other Credit Losses | Amount of expense related to credit loss from transactions other than loan and lease transactions. |
| Investment Income Amortization Of Discount | us-gaap/2023 | 0 | 0 | monetary | D | C | Investment Income, Amortization of Discount | Amount of accretion of purchase discount on nonoperating securities. |
| Common Stock Value | us-gaap/2023 | 0 | 0 | monetary | I | C | Common stock, $0.001 par value; 100,000,000 and 50,000,000 shares authorized as of December 31, 2022 and December 31, 2021; 15,193,587 and 13,466,603 shares issued as of December 31, 2022 and December 31, 2021, respectively; 15,166,596 and 13,439,612 shares outstanding as of December 31, 2022 and December 31, 2021, respectively | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Earnings Per Share Basic | us-gaap/2023 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Preferred Stock Shares Outstanding | us-gaap/2023 | 0 | 0 | shares | I | Preferred stock, shares outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Asset Impairment Charges | us-gaap/2023 | 0 | 0 | monetary | D | D | Asset Impairment Charges | Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | us-gaap/2023 | 0 | 0 | monetary | D | D | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. |
| Increase Decrease In Accounts Receivable | us-gaap/2023 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Intangible Assets Net Excluding Goodwill | us-gaap/2023 | 0 | 0 | monetary | I | D | Intangible Assets, Net (Excluding Goodwill) | Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. |
| Marketable Securities Current | us-gaap/2023 | 0 | 0 | monetary | I | D | Marketable Securities, Current | Amount of investment in marketable security, classified as current. |
| Proceeds From Stock Options Exercised | us-gaap/2023 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Restricted Cash Noncurrent | us-gaap/2023 | 0 | 0 | monetary | I | D | Restricted Cash, Noncurrent | Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Shares Issued | us-gaap/2023 | 0 | 0 | shares | I | Shares, Issued | Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. | |
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2023 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Demo Inventory Net | 0001558370-25-007462 | 1 | 0 | monetary | I | D | Demo Inventory Net | Amount after accumulated depreciation, depletion and amortization of demo equipment which is considered a hybrid between fixed asset and regular inventory. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2023 | 0 | 0 | monetary | D | C | Share-based expense | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Common Stock Shares Issued | us-gaap/2023 | 0 | 0 | shares | I | Common stock, shares issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Income Tax Expense Benefit | us-gaap/2023 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Liabilities And Stockholders Equity | us-gaap/2023 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2023 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Research And Development Expense | us-gaap/2023 | 0 | 0 | monetary | D | D | Research and development expenses | The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2023 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Profit Loss | us-gaap/2023 | 0 | 0 | monetary | D | C | Net Loss January 31,2023 | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Capital Expenditures Incurred But Not Yet Paid | us-gaap/2023 | 0 | 0 | monetary | D | C | Capital Expenditures Incurred but Not yet Paid | Future cash outflow to pay for purchases of fixed assets that have occurred. |
| Goodwill | us-gaap/2023 | 0 | 0 | monetary | I | D | Goodwill | Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. |
| Increase Decrease In Inventories | us-gaap/2023 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Refunds From Payments Of Deferred Offering Costs | 0001558370-25-007462 | 1 | 0 | monetary | D | D | Refunds From (Payments Of) Deferred Offering Costs | Refunds from previous payments or payments of current specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. |
| Restricted Stock Expense Number Of Shares | 0001558370-25-007462 | 1 | 0 | shares | D | Restricted Stock Expense, Number Of Shares | Number of shares of restricted stock vesting during the period. | |
| Net Income Loss | us-gaap/2023 | 0 | 0 | monetary | D | C | Net loss | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Assets Current | us-gaap/2023 | 0 | 0 | monetary | I | D | Assets, Current | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. |
| Common Stock Shares Outstanding | us-gaap/2023 | 0 | 0 | shares | I | Common stock, shares outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Earnings Per Share Diluted | us-gaap/2023 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Net Cash Provided By Used In Operating Activities | us-gaap/2023 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Gross Profit | us-gaap/2023 | 0 | 0 | monetary | D | C | GROSS MARGIN | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Operating Lease Liability Current | us-gaap/2023 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Operating Lease Right Of Use Asset | us-gaap/2023 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2023 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent. |
| Payments To Acquire Marketable Securities | us-gaap/2023 | 0 | 0 | monetary | D | C | Payments to Acquire Marketable Securities | Amount of cash outflow for purchase of marketable security. |
| Selling General And Administrative Expense | us-gaap/2023 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
| Change In Inventory Reserve Adjustment | 0001558370-25-007462 | 1 | 0 | monetary | D | D | Change In Inventory Reserve Adjustment | Amount of adjustment, related to inventory reserves, to net income to determine operating cash flow for the period. |
| Operating Lease Adjustment | 0001558370-25-007462 | 1 | 0 | monetary | D | D | Operating Lease Adjustment | Amount of adjustment, related to operating lease right-of-use asset, to net income to determine operating cash flow for the period. |
| Other Nonoperating Income Expense | us-gaap/2023 | 0 | 0 | monetary | D | C | Other income (expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Property Plant And Equipment Net | us-gaap/2023 | 0 | 0 | monetary | I | D | Property and equipment, net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Increase Decrease In Accounts Payable | us-gaap/2023 | 0 | 0 | monetary | D | D | Increase/(decrease) in accounts payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2023 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Deferred Income Tax Expense Benefit | us-gaap/2023 | 0 | 0 | monetary | D | D | Deferred Income Tax Expense (Benefit) | Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. |
| Finance Lease Liability Noncurrent | us-gaap/2023 | 0 | 0 | monetary | I | C | Finance Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent. |
| Finance Lease Principal Payments | us-gaap/2023 | 0 | 0 | monetary | D | C | Finance Lease, Principal Payments | Amount of cash outflow for principal payment on finance lease. |
| Finance Lease Right Of Use Asset | us-gaap/2023 | 0 | 0 | monetary | I | D | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | Amount, after accumulated amortization, of right-of-use asset from finance lease. |
| Increase Decrease In Contract With Customer Liability | us-gaap/2023 | 0 | 0 | monetary | D | D | Increase (Decrease) in Contract with Customer, Liability | Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable. |
| Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2023 | 0 | 0 | monetary | D | C | Payment, Tax Withholding, Share-Based Payment Arrangement | Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement. |
| Additional Paid In Capital | us-gaap/2023 | 0 | 0 | monetary | I | C | Additional paid in capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Assets | us-gaap/2023 | 0 | 0 | monetary | I | D | Assets | Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. |
| Common Stock Shares Authorized | us-gaap/2023 | 0 | 0 | shares | I | Common stock, shares authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Retained Earnings Accumulated Deficit | us-gaap/2023 | 0 | 0 | monetary | I | C | Accumulated deficit | Amount of accumulated undistributed earnings (deficit). |
| Interest And Other Income | us-gaap/2023 | 0 | 0 | monetary | D | C | Interest and Other Income | The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). |
| Payments To Acquire Property Plant And Equipment | us-gaap/2023 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2023 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Preferred Stock Value | us-gaap/2023 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2023 | 0 | 0 | shares | D | Options exercised | Number of share options (or share units) exercised during the current period. | |
| Cost Of Revenue | us-gaap/2023 | 0 | 0 | monetary | D | D | COST OF SALES | The aggregate cost of goods produced and sold and services rendered during the reporting period. |
| Depreciation Depletion And Amortization | us-gaap/2023 | 0 | 0 | monetary | D | D | Depreciation expense | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Contract With Customer Liability Current | us-gaap/2023 | 0 | 0 | monetary | I | C | Contract with Customer, Liability, Current | Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. |
| Finance Lease Liability Current | us-gaap/2023 | 0 | 0 | monetary | I | C | Finance Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from finance lease, classified as current. |
| Long Term Debt Noncurrent | us-gaap/2023 | 0 | 0 | monetary | I | C | Long-Term Debt, Excluding Current Maturities | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation. |
| Other Assets Current | us-gaap/2023 | 0 | 0 | monetary | I | D | Other Assets, Current | Amount of current assets classified as other. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2023 | 0 | 0 | perShare | I | Common stock, par value | Face amount or stated value per share of common stock. | |
| Liabilities | us-gaap/2023 | 0 | 0 | monetary | I | C | Liabilities | Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2023 | 0 | 0 | perShare | I | Preferred stock, par value | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Increase Decrease In Accrued Liabilities | us-gaap/2023 | 0 | 0 | monetary | D | D | Increase/(decrease) in accrued expenses | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Inventory Net | us-gaap/2023 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2023 | 0 | 0 | shares | I | Preferred stock shares issued | Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. | |
| Share Based Compensation | us-gaap/2023 | 0 | 0 | monetary | D | D | Share-based compensation | Amount of noncash expense for share-based payment arrangement. |
| Amortization Of Debt Discount Premium | us-gaap/2023 | 0 | 0 | monetary | D | D | Amortization of Debt Discount (Premium) | Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. |
| Interest Income Expense Nonoperating Net | us-gaap/2023 | 0 | 0 | monetary | D | C | Interest Income (Expense), Nonoperating, Net | The net amount of nonoperating interest income (expense). |
| Other Liabilities Noncurrent | us-gaap/2023 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Accounts Payable Current | us-gaap/2023 | 0 | 0 | monetary | I | C | Accounts payable | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Accrued Liabilities Current | us-gaap/2023 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Liabilities Current | us-gaap/2023 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2023 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Operating Expenses | us-gaap/2023 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Stockholders Equity | us-gaap/2023 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2023 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Accounts Receivable Net Current | us-gaap/2023 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Comprehensive Income Net Of Tax | us-gaap/2023 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2023 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Long Term Debt Current | us-gaap/2023 | 0 | 0 | monetary | I | C | Long-Term Debt, Current Maturities | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation. |
| Other Restructuring Costs | us-gaap/2023 | 0 | 0 | monetary | D | D | Other Restructuring Costs | Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation. |
| Restricted Stock Expense | us-gaap/2023 | 0 | 0 | monetary | D | D | Restricted Stock or Unit Expense | Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001558370-25-007462 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2023 | Cash and cash equivalents | 0 |
| 0001558370-25-007462 | 2 | 4 | BS | 0 | H | Marketable Securities Current | us-gaap/2023 | Marketable securities | 0 |
| 0001558370-25-007462 | 2 | 5 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2023 | Accounts receivable, net | 0 |
| 0001558370-25-007462 | 2 | 6 | BS | 0 | H | Inventory Net | us-gaap/2023 | Inventories, net | 0 |
| 0001558370-25-007462 | 2 | 7 | BS | 0 | H | Other Assets Current | us-gaap/2023 | Prepaid expenses and other current assets | 0 |
| 0001558370-25-007462 | 2 | 8 | BS | 0 | H | Assets Current | us-gaap/2023 | Total current assets | 0 |
| 0001558370-25-007462 | 2 | 9 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2023 | Property and equipment, net | 0 |
| 0001558370-25-007462 | 2 | 10 | BS | 0 | H | Restricted Cash Noncurrent | us-gaap/2023 | Restricted cash | 0 |
| 0001558370-25-007462 | 2 | 11 | BS | 0 | H | Demo Inventory Net | 0001558370-25-007462 | Demo inventory, net | 0 |
| 0001558370-25-007462 | 2 | 12 | BS | 0 | H | Intangible Assets Net Excluding Goodwill | us-gaap/2023 | Intangible assets, net | 0 |
| 0001558370-25-007462 | 2 | 13 | BS | 0 | H | Goodwill | us-gaap/2023 | Goodwill | 0 |
| 0001558370-25-007462 | 2 | 14 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2023 | Operating lease right of use assets, net | 0 |
| 0001558370-25-007462 | 2 | 15 | BS | 0 | H | Finance Lease Right Of Use Asset | us-gaap/2023 | Financing lease right of use assets, net | 0 |
| 0001558370-25-007462 | 2 | 16 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2023 | Other assets | 0 |
| 0001558370-25-007462 | 2 | 17 | BS | 0 | H | Assets | us-gaap/2023 | Total assets | 0 |
| 0001558370-25-007462 | 2 | 20 | BS | 0 | H | Accounts Payable Current | us-gaap/2023 | Accounts payable | 0 |
| 0001558370-25-007462 | 2 | 21 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2023 | Accrued expenses and other current liabilities | 0 |
| 0001558370-25-007462 | 2 | 22 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2023 | Current portion of operating lease liabilities | 0 |
| 0001558370-25-007462 | 2 | 23 | BS | 0 | H | Finance Lease Liability Current | us-gaap/2023 | Current portion of financing lease liabilities | 0 |
| 0001558370-25-007462 | 2 | 24 | BS | 0 | H | Contract With Customer Liability Current | us-gaap/2023 | Deferred revenue | 0 |
| 0001558370-25-007462 | 2 | 25 | BS | 0 | H | Long Term Debt Current | us-gaap/2023 | Current portion of long-term debt, net of debt discount | 0 |
| 0001558370-25-007462 | 2 | 26 | BS | 0 | H | Liabilities Current | us-gaap/2023 | Total current liabilities | 0 |
| 0001558370-25-007462 | 2 | 27 | BS | 0 | H | Contract With Customer Liability Noncurrent | us-gaap/2023 | Deferred revenue, net of current portion | 0 |
| 0001558370-25-007462 | 2 | 28 | BS | 0 | H | Long Term Debt Noncurrent | us-gaap/2023 | Long-term debt, net of current portion and debt discount | 0 |
| 0001558370-25-007462 | 2 | 29 | BS | 0 | H | Deferred Income Tax Liabilities Net | us-gaap/2023 | Deferred tax liability, net | 0 |
| 0001558370-25-007462 | 2 | 30 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2023 | Operating lease liabilities, net of current portion | 0 |
| 0001558370-25-007462 | 2 | 31 | BS | 0 | H | Finance Lease Liability Noncurrent | us-gaap/2023 | Financing lease liabilities, net of current portion | 0 |
| 0001558370-25-007462 | 2 | 32 | BS | 0 | H | Business Combination Contingent Consideration Liability Noncurrent | us-gaap/2023 | Contingent consideration liability, net of current portion | 0 |
| 0001558370-25-007462 | 2 | 33 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2023 | Other liabilities | 0 |
| 0001558370-25-007462 | 2 | 34 | BS | 0 | H | Liabilities | us-gaap/2023 | Total liabilities | 0 |
| 0001558370-25-007462 | 2 | 36 | BS | 0 | H | Preferred Stock Value | us-gaap/2023 | Preferred Stock, $0.00001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001558370-25-007462 | 2 | 37 | BS | 0 | H | Common Stock Value | us-gaap/2023 | Common Stock, $0.00001 par value; 500,000,000 shares authorized at March 31, 2025 and December 31, 2024; 49,836,931 and 49,572,122 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001558370-25-007462 | 2 | 38 | BS | 0 | H | Additional Paid In Capital | us-gaap/2023 | Additional paid in capital | 0 |
| 0001558370-25-007462 | 2 | 39 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2023 | Accumulated deficit | 0 |
| 0001558370-25-007462 | 2 | 40 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2023 | Accumulated other comprehensive (loss) income | 0 |
| 0001558370-25-007462 | 2 | 41 | BS | 0 | H | Stockholders Equity | us-gaap/2023 | Total stockholders' (deficit) equity | 0 |
| 0001558370-25-007462 | 2 | 42 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2023 | Total liabilities and stockholders' (deficit) equity | 0 |
| 0001558370-25-007462 | 3 | 1 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2023 | Preferred stock, par value | 0 |
| 0001558370-25-007462 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2023 | Preferred stock, shares authorized | 0 |
| 0001558370-25-007462 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2023 | Preferred stock, shares issued | 0 |
| 0001558370-25-007462 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2023 | Preferred stock, shares outstanding | 0 |
| 0001558370-25-007462 | 3 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2023 | Common stock, par value | 0 |
| 0001558370-25-007462 | 3 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2023 | Common stock, shares authorized | 0 |
| 0001558370-25-007462 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2023 | Common stock, shares issued | 0 |
| 0001558370-25-007462 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2023 | Common stock, shares outstanding | 0 |
| 0001558370-25-007462 | 4 | 7 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2023 | Revenue | 0 |
| 0001558370-25-007462 | 4 | 8 | IS | 0 | H | Cost Of Revenue | us-gaap/2023 | Cost of goods sold | 0 |
| 0001558370-25-007462 | 4 | 9 | IS | 0 | H | Gross Profit | us-gaap/2023 | Gross profit | 0 |
| 0001558370-25-007462 | 4 | 11 | IS | 0 | H | Selling General And Administrative Expense | us-gaap/2023 | Selling, general and administrative | 0 |
| 0001558370-25-007462 | 4 | 12 | IS | 0 | H | Research And Development Expense | us-gaap/2023 | Research and development | 0 |
| 0001558370-25-007462 | 4 | 13 | IS | 0 | H | Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | us-gaap/2023 | Change in fair value of contingent consideration | 0 |
| 0001558370-25-007462 | 4 | 14 | IS | 0 | H | Asset Impairment Charges | us-gaap/2023 | Impairment | 0 |
| 0001558370-25-007462 | 4 | 15 | IS | 0 | H | Other Restructuring Costs | us-gaap/2023 | Restructuring | 0 |
| 0001558370-25-007462 | 4 | 16 | IS | 0 | H | Operating Expenses | us-gaap/2023 | Total operating expenses | 0 |
| 0001558370-25-007462 | 4 | 17 | IS | 0 | H | Operating Income Loss | us-gaap/2023 | Loss from operations | 0 |
| 0001558370-25-007462 | 4 | 19 | IS | 0 | H | Interest Income Expense Nonoperating Net | us-gaap/2023 | Interest expense | 0 |
| 0001558370-25-007462 | 4 | 20 | IS | 0 | H | Interest And Other Income | us-gaap/2023 | Interest income | 0 |
| 0001558370-25-007462 | 4 | 21 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2023 | Other expense, net | 0 |
| 0001558370-25-007462 | 4 | 22 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2023 | Loss before provision for income taxes | 0 |
| 0001558370-25-007462 | 4 | 23 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2023 | Provision for income taxes | 1 |
| 0001558370-25-007462 | 4 | 24 | IS | 0 | H | Net Income Loss | us-gaap/2023 | Net loss | 0 |
| 0001558370-25-007462 | 4 | 25 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2023 | Net loss per share attributable to common stockholders, basic (in dollars per share) | 0 |
| 0001558370-25-007462 | 4 | 26 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2023 | Net loss per share attributable to common stockholders, diluted (in dollars per share) | 0 |
| 0001558370-25-007462 | 4 | 27 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2023 | Weighted-average shares outstanding, basic (in shares) | 0 |
| 0001558370-25-007462 | 4 | 28 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2023 | Weighted-average shares outstanding, diluted (in shares) | 0 |
| 0001558370-25-007462 | 5 | 1 | CI | 0 | H | Net Income Loss | us-gaap/2023 | Net loss | 0 |
| 0001558370-25-007462 | 5 | 3 | CI | 0 | H | Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2023 | Unrealized loss on marketable securities | 0 |
| 0001558370-25-007462 | 5 | 4 | CI | 0 | H | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2023 | Total other comprehensive loss | 0 |
| 0001558370-25-007462 | 5 | 5 | CI | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2023 | Comprehensive loss | 0 |
| 0001558370-25-007462 | 6 | 10 | EQ | 0 | H | Stockholders Equity | us-gaap/2023 | Balance, beginning of period | 0 |
| 0001558370-25-007462 | 6 | 11 | EQ | 0 | H | Shares Issued | us-gaap/2023 | Balance, beginning of period (in shares) | 0 |
| 0001558370-25-007462 | 6 | 12 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2023 | Exercise of stock options | 0 |
| 0001558370-25-007462 | 6 | 13 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2023 | Exercise of stock options (in shares) | 0 |
| 0001558370-25-007462 | 6 | 14 | EQ | 0 | H | Restricted Stock Expense | us-gaap/2023 | Vesting of restricted stock units | 1 |
| 0001558370-25-007462 | 6 | 15 | EQ | 0 | H | Restricted Stock Expense Number Of Shares | 0001558370-25-007462 | Vesting of restricted stock units (in shares) | 0 |
| 0001558370-25-007462 | 6 | 16 | EQ | 0 | H | Net Income Loss | us-gaap/2023 | Net Income (Loss) | 0 |
| 0001558370-25-007462 | 6 | 17 | EQ | 0 | H | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2023 | Other comprehensive loss | 0 |
| 0001558370-25-007462 | 6 | 18 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2023 | Stock-based compensation | 0 |
| 0001558370-25-007462 | 6 | 19 | EQ | 0 | H | Stockholders Equity | us-gaap/2023 | Balance, end of period | 0 |
| 0001558370-25-007462 | 6 | 20 | EQ | 0 | H | Shares Issued | us-gaap/2023 | Balance, end of period (in shares) | 0 |
| 0001558370-25-007462 | 7 | 2 | CF | 0 | H | Profit Loss | us-gaap/2023 | Net loss | 0 |
| 0001558370-25-007462 | 7 | 4 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2023 | Depreciation and amortization | 0 |
| 0001558370-25-007462 | 7 | 5 | CF | 0 | H | Amortization Of Debt Discount Premium | us-gaap/2023 | Non-cash interest expense | 0 |
| 0001558370-25-007462 | 7 | 6 | CF | 0 | H | Share Based Compensation | us-gaap/2023 | Stock-based compensation expense | 0 |
| 0001558370-25-007462 | 7 | 7 | CF | 0 | H | Deferred Income Tax Expense Benefit | us-gaap/2023 | Deferred taxes | 0 |
| 0001558370-25-007462 | 7 | 8 | CF | 0 | H | Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | us-gaap/2023 | Change in fair value of contingent consideration | 0 |
| 0001558370-25-007462 | 7 | 9 | CF | 0 | H | Provision For Other Credit Losses | us-gaap/2023 | Credit losses on accounts receivable | 0 |
| 0001558370-25-007462 | 7 | 10 | CF | 0 | H | Investment Income Amortization Of Discount | us-gaap/2023 | Net accretion of marketable securities | 1 |
| 0001558370-25-007462 | 7 | 11 | CF | 0 | H | Operating Lease Adjustment | 0001558370-25-007462 | Operating lease right of use assets | 0 |
| 0001558370-25-007462 | 7 | 12 | CF | 0 | H | Change In Inventory Reserve Adjustment | 0001558370-25-007462 | Provision for excess and obsolete inventories | 0 |
| 0001558370-25-007462 | 7 | 13 | CF | 0 | H | Asset Impairment Charges | us-gaap/2023 | Impairment | 0 |
| 0001558370-25-007462 | 7 | 15 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2023 | Accounts receivable, net | 1 |
| 0001558370-25-007462 | 7 | 16 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2023 | Prepaid expenses and other assets | 1 |
| 0001558370-25-007462 | 7 | 17 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2023 | Inventories, net | 1 |
| 0001558370-25-007462 | 7 | 18 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2023 | Accounts payable | 0 |
| 0001558370-25-007462 | 7 | 19 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2023 | Accrued expenses and other liabilities | 0 |
| 0001558370-25-007462 | 7 | 20 | CF | 0 | H | Increase Decrease In Operating Lease Liabilities | 0001558370-25-007462 | Operating lease liabilities | 0 |
| 0001558370-25-007462 | 7 | 21 | CF | 0 | H | Increase Decrease In Contract With Customer Liability | us-gaap/2023 | Deferred revenue | 0 |
| 0001558370-25-007462 | 7 | 22 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2023 | Net cash used in operating activities | 0 |
| 0001558370-25-007462 | 7 | 24 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2023 | Purchases of property and equipment | 1 |
| 0001558370-25-007462 | 7 | 25 | CF | 0 | H | Payments To Acquire Marketable Securities | us-gaap/2023 | Purchases of marketable securities | 1 |
| 0001558370-25-007462 | 7 | 26 | CF | 0 | H | Maturities Of Marketable Securities | 0001558370-25-007462 | Maturities of marketable securities | 0 |
| 0001558370-25-007462 | 7 | 27 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2023 | Net cash provided by (used in) investing activities | 0 |
| 0001558370-25-007462 | 7 | 29 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2023 | Proceeds from stock option exercises | 0 |
| 0001558370-25-007462 | 7 | 30 | CF | 0 | H | Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2023 | Settlement of restricted stock units for tax withholding obligations | 1 |
| 0001558370-25-007462 | 7 | 31 | CF | 0 | H | Finance Lease Principal Payments | us-gaap/2023 | Principal payments on financing leases | 1 |
| 0001558370-25-007462 | 7 | 32 | CF | 0 | H | Refunds From Payments Of Deferred Offering Costs | 0001558370-25-007462 | Payments of deferred offering costs | 0 |
| 0001558370-25-007462 | 7 | 33 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2023 | Net cash used in financing activities | 0 |
| 0001558370-25-007462 | 7 | 34 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2023 | Net increase (decrease) in cash, cash equivalents, and restricted cash | 0 |
| 0001558370-25-007462 | 7 | 35 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2023 | Cash, cash equivalents, and restricted cash at beginning of period | 0 |
| 0001558370-25-007462 | 7 | 36 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2023 | Cash, cash equivalents, and restricted cash at end of period | 0 |
| 0001558370-25-007462 | 7 | 38 | CF | 0 | H | Interest Paid Net | us-gaap/2023 | Cash paid for interest | 0 |
| 0001558370-25-007462 | 7 | 40 | CF | 0 | H | Capital Expenditures Incurred But Not Yet Paid | us-gaap/2023 | Purchases of property and equipment included in accounts payable and accrued expenses | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |